David Altshuler - Feb 17, 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Signature
/s/ Sabrina Yohai, Attorney-in-Fact
Stock symbol
VRTX
Transactions as of
Feb 17, 2022
Transactions value $
-$1,795,551
Form type
4
Date filed
2/22/2022, 03:51 PM
Previous filing
Feb 16, 2022
Next filing
Feb 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Tax liability -$800K -3.44K -5.99% $232.51 54K Feb 17, 2022 Direct
transaction VRTX Common Stock Sale -$226K -986 -1.83% $229.22 53K Feb 18, 2022 Direct F1, F2, F3
transaction VRTX Common Stock Sale -$300K -1.3K -2.46% $230.05 51.7K Feb 18, 2022 Direct F1, F3, F4
transaction VRTX Common Stock Sale -$88.9K -385 -0.74% $231.01 51.3K Feb 18, 2022 Direct F1, F3, F5
transaction VRTX Common Stock Sale -$139K -600 -1.17% $231.85 50.7K Feb 18, 2022 Direct F1, F3, F6
transaction VRTX Common Stock Sale -$242K -1.04K -2.05% $233.27 49.7K Feb 18, 2022 Direct F1, F3, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Mr. Altshuler's company approved trading plan under Rule 10b5-1.
F2 Open market sales reported on this line occurred at a weighted average price of $229.22 (range $228.65 to $229.60).
F3 Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F4 Open market sales reported on this line occurred at a weighted average price of $230.05 (range $229.65 to $230.59).
F5 Open market sales reported on this line occurred at a weighted average price of $231.01 (range $230.66 to $231.43).
F6 Open market sales reported on this line occurred at a weighted average price of $231.85 (range $231.67 to $232.01).
F7 Open market sales reported on this line occurred at a weighted average price of $233.27 (range $232.91 to $233.50).